ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Active funds frequently lag behind due to fees and manager risk, while index funds provide broad exposure with lower costs and smoother performance.
22,822 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
XRP has retaken a pivotal resistance as May 2026 momentum builds, signaling a possible breakout. Traders watch key le...
Rising debt costs and energy shocks are echoing through crypto markets. Analysts warn the signs point to tripwires th...
Republic Services is tightening up near key moving averages, raising odds for a golden cross. This report surveys the...
Stocks are riding high on robust earnings, but a looming bear market appears increasingly likely as rate paths and st...
The S&P 500 endured a 14-year stretch of flat nominal growth while inflation ate away buying power, resulting in a 40...
Geopolitical tension in the Middle East sparked a swift crypto reaction, with Bitcoin swinging as officials weigh a p...
Midday trading shows inflation fears and global tensions pressing equities. This update breaks down what’s moving the...
Palantir stock has cooled after a run of gains and is trading near its 52-week low. This guide explores what that mea...
XLV faces a pivotal year as it tracking to beat the S&P 500 in 2026. Analysts say two factors that will decide its fa...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...
Breaking news: President Trump signals sweeping tariffs on digital services taxes, shaking tech stocks and forcing in...